PATANASE (ALCON LABORATORIES, INC.)
Welcome to the PulseAid listing for the PATANASE drug offered from ALCON LABORATORIES, INC.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ALCON LABORATORIES, INC. |
| NON-PROPRIETARY NAME: | olopatadine hydrochloride |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-04-28 |
| END MARKETING DATE: | 0000-00-00 |
PATANASE HUMAN PRESCRIPTION DRUG Details:
| Item Description | PATANASE from ALCON LABORATORIES, INC. |
| LABELER NAME: | ALCON LABORATORIES, INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(ug/1) |
| START MARKETING DATE: | 2008-04-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0065-0332_4ce345c6-362e-d0e4-5792-2d0f5ccc9bfd |
| PRODUCT NDC: | 0065-0332 |
| APPLICATION NUMBER: | NDA021861 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
